title: The novel Kv1.5 channel blocker vernakalant for successful treatment of new-onset atrial fibrillation in a critically ill abdominal surgical patient.
authors: P
authors: P
authors: Friederich
authors: H
authors: H
authors: Pfizenmayer
mesh_terms: D000005:Abdomen / Q000601:surgery*; D000368:Aged; D000840:Anisoles / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000209:etiology; D016638:Critical Illness; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D045823:Ileus / Q000601:surgery; D051666:Kv1.5 Potassium Channel / Q000037:antagonists & inhibitors*; D007813:Laparotomy; D011183:Postoperative Complications / Q000188:drug therapy*; D011759:Pyrrolidines / Q000627:therapeutic use*
chemical_list: D000840:Anisoles; C496981:KCNA5 protein, human; D051666:Kv1.5 Potassium Channel; D011759:Pyrrolidines; C524581:vernakalant